Cue Biopharma's total assets for Q1 2026 were $30.88M, a decrease of -26.85% from the previous quarter. CUE total liabilities were $9.27M for the fiscal quarter, a -41.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.